Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2008-02-14 Major Shareholding Noti…
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
DOC ONE
Major Shareholding Notification
2008-02-14 English
FORM 6-K
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 6-K' and is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. It contains unaudited condensed consolidated financial statements for the quarterly period ended September 30, 2007, including balance sheets, statements of operations, cash flows, and notes. The presence of quarterly financial data and the SEC Form 6-K designation indicates this is an interim or quarterly report filed by a foreign issuer. The document is substantive and contains actual financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2007-11-14 English
Regulatory Filings 2007
Regulatory Filings
2007-10-01 English
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a response letter from QIAGEN N.V. to the SEC staff comments regarding their Form 20-F filing for the fiscal year ended December 31, 2006. It addresses specific SEC comments on financial statement disclosures and accounting treatments, indicating it is a correspondence related to a regulatory filing rather than the filing itself. The letter references the Form 20-F but does not contain the actual financial statements or substantive financial data. It is a regulatory correspondence responding to SEC comments, which fits the category of Regulatory Filings (RNS) as a fallback for such documents that do not fit other categories.
2007-08-31 English
FORM 6-K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, QIAGEN N.V., pursuant to SEC rules. It contains unaudited condensed consolidated financial statements for the quarterly period ended June 30, 2007, including balance sheets, income statements, cash flow statements, notes, and management's operating and financial review. The presence of detailed interim financial data and analysis for a period shorter than a full fiscal year (quarterly period) indicates this is an Interim / Quarterly Report. The document is about 15,000 characters, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2007-08-14 English
RULE 424(B)(3)
Merger & Acquisition Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(3) related to a merger transaction involving Digene Corporation and Qiagen N.V. It provides detailed information about the merger, appraisal rights, payment procedures, and legal references under Delaware law. The document includes a notice of merger and appraisal rights, terms of the merger consideration, and instructions for shareholders. It is not a full annual or quarterly report, nor is it a simple announcement or certification. The content is focused on merger-related information and shareholder rights, consistent with filings related to merger communications. The presence of the Rule 424(b)(3) filing and detailed merger terms indicates this is a merger-related filing, specifically a prospectus supplement related to a merger transaction. According to the filing definitions, this fits best under the category of Merger & Acquisition (MA), which includes merger communications such as Form 425 and related filings. Therefore, the document should be classified as Merger & Acquisition (MA).
2007-08-07 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.